Yahoo Web Search

Search results

    • Ipsen drug for rare liver disease approved by FDA

      Ipsen drug for rare liver disease approved by FDA

      BioPharma Dive via Yahoo Finance· 3 days ago

      The medicine will join Intercept’s Ocaliva as a treatment option for primary biliary cholangitis. Another drug, from the now Gilead-owned CymaBay, could...